Calcineurin inhibitors in renal transplantation: what is the best option? (Q35187355)

7 August 2017

1 reference

title

Calcineurin inhibitors in renal transplantation: what is the best option? (English)

1 reference

7 August 2017

Kazunari Tanabe

1

1 reference

7 August 2017

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

63

1 reference

7 August 2017

15

1 reference

7 August 2017

1535-1548

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363150-00002

7 August 2017

0 references

cites work

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

1 reference

12 December 2020

Corticosteroid withdrawal in renal transplantation

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

1 reference

12 December 2020

Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?

1 reference

12 December 2020

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

12 December 2020

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

12 December 2020

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience

1 reference

12 December 2020

Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids

1 reference

12 December 2020

Withdrawal of steroids after renal transplantation--clinical predictors of outcome

1 reference

12 December 2020

New small molecule immunosuppressants for transplantation: review of essential concepts.

1 reference

12 December 2020

Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial

1 reference

12 December 2020

The side-effects of ciclosporine-A and tacrolimus

1 reference

12 December 2020

Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation

1 reference

12 December 2020

Tacrolimus and glucose metabolism

1 reference

12 December 2020

A ten-year prediction for kidney transplant survival

1 reference

12 December 2020

Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis

1 reference

12 December 2020

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

1 reference

12 December 2020

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus

1 reference

12 December 2020

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

12 December 2020

Rapamycin: clinical results and future opportunities

1 reference

12 December 2020

Withdrawal of steroids from a cyclosporine-based regimen: pro

1 reference

12 December 2020

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications

1 reference

12 December 2020

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

1 reference

12 December 2020

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.

1 reference

12 December 2020

Maintenance immunosuppression: new agents and persistent dilemmas

1 reference

12 December 2020

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

1 reference

12 December 2020

A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy

1 reference

12 December 2020

Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial

1 reference

12 December 2020

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

12 December 2020

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

12 December 2020

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years

1 reference

12 December 2020

Mechanisms of action of new immunosuppressive drugs.

1 reference

12 December 2020

Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients

1 reference

12 December 2020

Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

1 reference

12 December 2020

A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

12 December 2020

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.

1 reference

12 December 2020

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

12 December 2020

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

1 reference

12 December 2020

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients

1 reference

12 December 2020

A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation

1 reference

12 December 2020

Pharmacology of immunosuppressive medications used in renal diseases and transplantation

1 reference

12 December 2020

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression

1 reference

12 December 2020

Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression

1 reference

12 December 2020

Prevention of transplant rejection: current treatment guidelines and future developments

1 reference

12 December 2020

Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression

1 reference

12 December 2020

Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression

1 reference

12 December 2020

10.2165/00003495-200363150-00002

Identifiers

DOI

1 reference

PubMed ID

12887261

Dimensions Publication ID

7 August 2017

0 references

1 reference

PubMed ID

12887261